Botanical species · safety record

Clinopodium nepeta

The EFSA Compendium of Botanicals holds 13 constituent measurements for Clinopodium nepeta. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Clinopodium nepeta (L.) Kuntze

13Constituent measurements

0Safety records

4Cited sources

0Licensed products (Canada)

Also recorded as

Calamintha nepeta (L.) Savi
Calamintha vulgaris Clairv.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
(+)-pulegone	Unspecified	Solvent extraction	≤ 52.3 Percent	GC-MS	Resolve DOI
(+)-pulegone	Unspecified	Solvent extraction	—	—	Resolve DOI
(+)-pulegone	Unspecified	Solvent extraction	≥ 1.3 Percent	GC-MS	Resolve DOI
(+)-pulegone	Aerial part of plants	Solvent extraction	735.44 Percent	GC-MS	Resolve DOI
Camphor	Unspecified	Solvent extraction	—	—	Resolve DOI
Menthone	Unspecified	Solvent extraction	≤ 17.1 Percent	—	Resolve DOI
Menthone	Unspecified	Solvent extraction	≥ 2.6 Percent	—	Resolve DOI
P-menth-1-en-3-one	Aerial part of plants	Solvent extraction	1.5 Percent	GC-MS	Resolve DOI
Piperitenone oxide	Unspecified	Solvent extraction	≤ 35.4 Percent	—	Resolve DOI
Piperitenone oxide	Unspecified	Solvent extraction	≥ 4.8 Percent	—	Resolve DOI
Piperitone oxide	Unspecified	Solvent extraction	≥ 7.5 Percent	—	Resolve DOI
Piperitone oxide	Unspecified	Solvent extraction	≤ 33.8 Percent	—	Resolve DOI
Eugenol	Unspecified	Essential oil	—	GC-MS	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Araniti, Fabrizio., Grana, Elisa., Reigosa, Manuel J., Sanchez-Moreiras, Adela M., Rosa Abenavoli, Maria. Individual and joint activity of terpenoids, isolated from Calamintha nepeta extract, on Arabidopsis thaliana. NATURAL PRODUCT RESEARCH, 2013, vol. 27, no. 24, p. 2297-2303. DOI
Mastelic, J., Milos, M., Kustrak, D., Radonic, A. The essential oil and glycosidically bound volatile compounds of Calamintha nepeta (L.) Savi. CROATICA CHEMICA ACTA, 1998, vol. 71, no. 1, p. 147-154.
Chizzola, R. Volatile compounds from some wild growing aromatic herbs of the Lamiaceae from southern France. PLANT BIOSYSTEMS, 2006, vol. 140, no. 2, p. 206-210. DOI
Araniti, Fabrizio., Lupini, Antonio., Mercati, Francesco., Statti, Giancarlo Antonio., Abenavoli, Maria Rosa. Calamintha nepeta L. (Savi) as source of phytotoxic compounds: bio-guided fractionation in identifying biological active molecules. ACTA PHYSIOLOGIAE PLANTARUM, 2013, vol. 35, no. 6, p. 1979-1988. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature